Background
==========

Gout is monosodium urate crystal-induced inflammatory arthritis associated with hyperuricemia.^[@bib1]^ The incidence of gout is estimated to be 0.2--0.4% worldwide, with an annual incidence of 0.01--0.015%.^[@bib2]^ Gout is more common in men with a male-to-female ratio of 4:1 below the age of 65 years and 3:1 above the age of 65 years.^[@bib3]^ Predisposing factors for an acute attack include trauma, surgery, increasing alcohol intake, high levels of intake of meat and fish and medications including diuretics and cyclosporine. Tophaceous gout is characterized by precipitation of urate crystals in the joints and periarticular tissues, and deposits commonly are found in the metatarsophalangeal joints, ankles, knees, wrists, fingers and shoulders. Gouty arthritis of the axial joints, particularly of the spine, is very rare.

Gout could involve all the segments of the spine. King *et al.* reviewed the records of reported cases of axial gouty tophi and \~44% of the axial gout patients had involvement of the lumbar vertebrae, 39% the cervical vertebrae and 17% the thoracic vertebrae.^[@bib4]^ Tophaceous gout could impact anatomic components of the spine, such as facet joint,^[@bib5]^ vertebral bodies,^[@bib6]^ pedicle,^[@bib7]^ lamina^[@bib8]^ and ligamentum flavum.^[@bib9]^ Patients present with features of spinal stenosis, lumbar radiculopathy, spondylolisthesis, cauda equine syndrome or spinal infection.

We present a case of a newly diagnosed patient with thoracic spine tophaceous gout involving the ligamentum flavum.

Case presentation
=================

A 54-year-old Chinese male with a 12-year history of gout and hyperuricemia reported a 3-day history of lower limb edema and elevated serum creatinine. He suffered episodic gouty attacks, despite intermittently being treated with nonsteroidal anti-inflammatory drugs. Tophaceous deposits were present in the hands and toes for at least 5 years. Furthermore, the patient reported high alcohol intake spanning 20 years. He denied any history of trauma or spinal injuries. After he had been admitted to inpatient ward, he was found to have tenderness in the left anterior leg with anesthesia. Five days later, he complained of progressive back pain radiating to his anterior chest. The level of skin anesthesia increased from the lower extremities to his chest. Several days later, the paraparesis progressed to difficulty walking.

On physical examination the patient was found to have a fever of 38.8 °C. He had significant tenderness in his back and obvious difficulty with ambulation secondary to pain. Multiple tophi were also noted over several interphalangeal joints and metatarsophalangeal joints. Neurological examination showed that his lower limb strength had decreased (Grade 4/5) on the left and he had left ankle clonus. The lower abdominal and cremasteric reflexes were normal. The left lower limb also showed exaggerated reflexes as well as positive Babinski and Rossolimo\' sign. Reflexes were intact and within normal range on the straight-leg raise test. Laboratory values at the time of admission are depicted in [Table 1](#tbl1){ref-type="table"}.

Computed tomography of the thoracic spine showed spinal stenosis at the T3/T4, T9-T12 levels. He also underwent magnetic resonance imaging, which showed hypertrophic ligamentum flavum at the level of T3/T4, T5/T6, T9/T10, T10/T11 and T11/T12 ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). The discs of T7/T8, L3/L4, and L5/S1 showed posterior bulge. Degenerative disc disease was found at the levels of T1/T2, T12/L1, L1/L2 and L5/S1.

A thoracic laminectomy was performed at T1-T5. During the operation, an abnormal mass with a white, chalky, cheese-like and granular appearance was observed. A culture of the chalky material revealed no bacterial growth. A histological examination of the material removed during the laminectomy showed amorphous eosinophilic material with thin needle-shaped crystals that were negatively birefringent on polarizing microscopy. Bacteriologic examinations were negative.

After his operation, his back pain and skin anesthesia of the lower extremities was markedly improved. He was prescribed allopurinol and transferred to a rehabilitation facility.

Discussion
==========

The first radiologic and pathologic description of gouty involvement of the spine was published by Kersley *et al.* in 1950.^[@bib10]^ However, the first case of thoracic gouty spine patient was not discussed until the report by Koskoff *et al.* in 1953.^[@bib11]^ To the best of our knowledge, 21 thoracic spine cases have been reported. The reported cases of spinal gout involvement of thoracic vertebrae are listed in [Table 2.](#tbl2){ref-type="table"}^[@bib7],\ [@bib11],\ [@bib12],\ [@bib13],\ [@bib14],\ [@bib15],\ [@bib16],\ [@bib17],\ [@bib18],\ [@bib19],\ [@bib20],\ [@bib21],\ [@bib22],\ [@bib23],\ [@bib24],\ [@bib25],\ [@bib26],\ [@bib27],\ [@bib28],\ [@bib29],\ [@bib30]^ There was significant gender difference with a male-to-female ratio of 17:4 in the reported cases. Fourteen (66.7%) patients reported a history of gout symptom ranging from 2 to 35 years.^[@bib11],\ [@bib12],\ [@bib13],\ [@bib15],\ [@bib16],\ [@bib17],\ [@bib18],\ [@bib19],\ [@bib20],\ [@bib22],\ [@bib23],\ [@bib24],\ [@bib25],\ [@bib30]^ Peripheral tophi were found in ten (47.6%) patients.^[@bib7],\ [@bib11],\ [@bib12],\ [@bib13],\ [@bib15],\ [@bib16],\ [@bib17],\ [@bib18],\ [@bib19],\ [@bib25]^ Although tophi were reported in all thoracic regions, the most frequent involvement was seen in the thoracic region at T7-T10 ([Figure 3](#fig3){ref-type="fig"}). The most common location of gouty tophi involvement was extradural space.^[@bib11],\ [@bib13],\ [@bib14],\ [@bib15],\ [@bib16],\ [@bib18],\ [@bib21],\ [@bib22],\ [@bib25],\ [@bib26]^ Other locations of axial elements, such as facet joints,^[@bib23],\ [@bib29],\ [@bib30]^ discs,^[@bib12]^ vertebral bodies,^[@bib7],\ [@bib12],\ [@bib17],\ [@bib19],\ [@bib20]^ pedicles^[@bib7],\ [@bib13],\ [@bib27],\ [@bib30]^ and costovertebral joint^[@bib28]^ have been reported. However, the formation of gouty tophi within the thoracic spine involving the ligamentum flavum causing spinal cord compression, as occurs in our case, have only been reported previously by Wang *et al.*^[@bib23]^ and Hus *et al.*^[@bib24]^

The prevalence of spinal gout is unclear since most of the available information comes from anecdotal case-reports. Konatalapalli *et al.*^[@bib31]^ reviewed 630 patients who were diagnosed with gouty arthritis, tophaceous gout or unspecified gout. Sixty-four patients had computed tomography images of cervical, thoracic or pelvic region. Spinal gout was identified in 9 of these 64 patients (14%). More recently, Konatalapalli *et al* accomplished a cross-sectional study regarding axial gout. Seventeen of the 48 subjects (35%) had computed tomography evidence of spinal gout and 7 (15%) had spinal tophi.^[@bib32]^ On the basis of these observational studies, we speculated that the prevalence of axial gouty tophi was grossly underestimated.

Although the etiopathogenesis of the crystal accumulation in the axial skeleton is not completely known, it has been reported that factors such as degenerative disease of the spine, necrosis of the tissues or previous injuries can trigger the process.^[@bib4],\ [@bib33],\ [@bib34]^ Meanwhile, some predisposing factors such as old age, low temperature, low serum pH level, renal insufficiency, diuretic and cyclospine A agent, IgA nephropathy and high alcohol intake are thought to promote tophi formation and development. The reason for the involvement of peripheral joints in gout is considered to be related to the decrease of the solubility of the crystals in the places with lower temperature and formation of tophi in avascular tissues.^[@bib4],\ [@bib35]^ In addition, lower blood pH causes a decrease in the binding plasma proteins and trauma causes an increase in the precipitation of urate crystals, both of which cause an increase in tophus formation.^[@bib4],\ [@bib35],\ [@bib36]^ In our review, most of the patients with gouty tophi involved T7 through T10, which was consistent with the possibility that inflammation associated with motion-related damage may create an environment favorable for urate deposition. Renal dysfunction plays a significant role in raising the uric acid levels of the serum. Primary or secondary renal function promotes uric acid levels, causing tophi deposition in the spine and mild spinal stenosis with abnormal nerve compression. In turn, the elevated serum acid level further impairs renal function and contributes to the worsening of tophi deposition, which is supported by Chonchol *et al.*^[@bib37]^ Our patient had a long history of hyperurecimia, with only intermittent pharmaceutical control. Subcutaneous deposition of gouty tophi in the right elbow area was also noted at this time. Thus, a relatively low environmental temperature and decreased renal urate clearance may be prerequisites for urate deposition.

Clinical manifestations of thoracic spinal gout range from back pain, unilateral or bilateral extremities paralysis, limbs weakness, sensory impaired to urinary retention. Neurologic symptoms were dependent on the level of the spine that was affected.

On MR, spinal tophi appear as homogeneous areas of intermediate-to-low signal intensity on T1-weighted images. On T2-weighted images, the signal intensity of the tophi varies from homogeneous hyperintensity to homogeneous hypointensity. This hyperintensity may result from a relative increase in the water content of the tophus and the relative homogeneity of local magnetic field within the tophi. In comparison, the T2-weighted hypointensity may be caused by immobile protons in the tophi. This appearance can be due to regions of calcifications, mature fibrous tissue, or hemosiderin deposition in the tophi. After gadolinium enhancement, the tophi show homogeneous or heterogeneous marginal enhancement. The enhancement of the tophi is thought to be the result of well-vascularized chronic, inflammatory fibrous tissue engendered by urate crystal deposition.^[@bib4],\ [@bib24]^

Gouty tophi are nodular, chalky white in the center, made of monosodium urate crystals, proteins, and mucopolysaccharides. Under microscopy, the urate depositions are found to be surrounded by multinucleated histiocytes, which are giant cells with foreign bodies associated with lymphoplasmocytic cells and fibroblasts. Moreover, monosodium urate crystals can be dissolved by formalin. This may be a reason why in our case there were no birefringent crystals under polarized light. It is important that the specimen should be properly fixed after biopsy or operation.

Surgical decompression such as laminectomy followed by optimization of pharmacological treatment can improve the patient\'s clinical symptoms and provide a good prognosis. Modification of risk factors such as alcohol consumption, improvement in renal function, or alteration of the diuretic regimen may be beneficial and should be pursued whenever possible. Frequent follow-ups and imaging studies may permit early diagnosis and minimized complications of this disease.

Conclusion
==========

In conclusion, although spinal gout maybe rare, it is important to be aware of this possibility. The clinician should include spinal gout as a differential diagnosis when dealing with patients with gout and axial pain with or without neurologic deficits. Even a short, uncontrolled period of time in the course of the disease could lead to devastating neurologic deficits necessitating emergent surgery for decompression. If this diagnosis is seriously entertained, then a computed tomography scan or magnetic resonance imaging as well as tissue biopsy may be needed to establish the diagnosis. If gout is suspected at the time of the biopsy, this needs to be communicated to the pathologist because monosodium urate crystals will dissolve during routine histologic processing.

We thank Dr Fangtan Li for providing magnetic resonance imaging figures.

**Author Contributions**

Z-F Zheng and Y Xing are responsible for patient clinical diagnosis and therapy. They also collected patient follow-up data and drafted the manuscript. H-L Shi collected the radiological data and provided interpretation. D Li and J-Y Jia reviewed the literature and summarized the data. S Lin prepared the final version of the manuscript. All authors read and approved the final manuscript.

The authors declare no conflict of interest.

![Sagittal image of hypointensity magnetic resonance imaging shows hypertrophy ligamentum flavum. (**a**) T1-weighted image shows the lesion at the T3-T4 level. (**b**) T1-weighted image shows the lesions at the T9-T10, T10-T11 and T11-T12 levels. (**c**) T2-weighted image shows the lesion at the T3-T4 level. (**d**) T2-weighted image shows the lesions at the T9-T10, T10-T11 and T11-T12 levels.](sc201593f1){#fig1}

![Axial images of hypointensity magnetic resonance imaging shows hypertrophy of the ligamentum flavum on T2-weighted image. (**a**) The lesion at the T3-T4 level. (**b**) The lesion at the T9-T10 level. (**c**) The lesion at the T10-T11 level. (**d**) The lesion at the T11-T12 level.](sc201593f2){#fig2}

![Distribution characteristics of reported tophaceous gout of the thoracic spine in the literature. (**a**) Distribution of the patient\'s age. (**b**) Distribution of the involved location.](sc201593f3){#fig3}

###### Laboratory data at presentation

  *Variable*                                                   *Result*   *Reference range*
  ----------------------------------------------------------- ---------- -------------------
  *Blood count*                                                          
   Leukocytes (10^9 ^l^−1^)                                      9.05         4.0--10.0
   Erythrocytes (10^12^ l^−1^)                                 **3.12**       4.0--5.5
   Hemoglobin (g dl^−1^)                                        **90**        120--160
   Hematocrit (%)                                              **26.4**      42.0--49.0
   Platelet count (10^9^ l^−1^)                                  247          100--300
                                                                         
  *Serum chemistry*                                                      
   Total protein (g l^−1^)                                        66           62--85
   Albumin (g l^−1^)                                              40           35--55
   Globulin (g l^−1^)                                             26           26--37
   Total cholesterol (mmol l^−1^)                                4.66        3.59--5.17
   Triglyceride (mmol l^−1^)                                   **2.1**       0.57--1.71
   Low density lipoprotein (mmol l^−1^)                          2.52        1.33--3.30
   Lactate dehydrogenase (U l^−1^)                               245           94--250
   Glutamic pyruvic transaminase (U l^−1^)                        16            5--40
   Glutamic oxaloacetic transaminase (U l^−1^)                    13            8--40
   Blood urea nitrogen (mmol l^−1^)                              7.6          1.7--8.3
   Serum creatinine (μmol l^−1^)                               **120**         44--115
   Serum uric acid (μmol l^−1^)                                  320          140--414
   Fasting blood glucose (mmol l^−1^)                          **6.2**        3.6--5.8
                                                                         
  *Immunology*                                                           
   Immunoglobulin G (mg dl^−1^)                                  991          751--1560
   Immunoglobulin A (mg dl^−1^)                                  171           82--453
   Immunoglobulin M (mg dl^−1^)                                   47           46--304
   Immunoglobulin E (IU ml^−1^)                                  116            \<165
   Complement C3 (mg dl^−1^)                                     152           79-152
   Complement C4 (mg dl^−1^)                                      38            16-38
   C-reactive protein (mg dl^−1^)                              **12.9**         \<0.8
   Circulating immune complexes (U ml^−1^)                       3.2            \<13
   Antinuclear antibodies                                      Negative       Negative
   Antibody against double-stranded DNA                        Negative       Negative
   Antibodies to extractable nuclear antigens                  Negative       Negative
   Anti-neutrophil cytoplasmic antibodies                      Negative       Negative
   Anti-glomerular basement membranous antibody (RU ml^−1^)      \<20           \<20
   Anti-cardiolipin antibody                                   Negative       Negative
   Anti-ribosomal P-protein antibody                           Negative       Negative
   Serum immunofixation electrophoresis                        Negative       Negative
   Anti-cyclic citndlinated peptide antibody (U ml^−1^)          6.4           \<12.0
   Anti-mutated citrullinated vimentin antibody (U ml^−1^)       5.2           \<20.0
   Anti-RA33 antibody (U ml^−1^)                                 11.3          \<25.0
   Anti-keratin antibody                                       Negative       Negative
   Anti-perinuclear factor antibody                            Negative       Negative
   Rheumatoid factor IgA subclass (U ml^−1^)                     8.8           \<12.0
   Rheumatoid factor IgG subclass (U ml^−1^)                     10.3          \<12.0

The bold and italic entries indicate abnormal values beyond the reference range.

###### Demographic and clinical characteristics of patients with tophaceous gout of the spine

  *Author*             *Publication year*   *Country*        *Age (years)*    *Gender*  *History of gout symptom (years)*   *Neurological symptoms*                                                             *Clinical description of gout*   *Serum uric acid level (μmol l^−1^)*    *Level of involvement*  *Location of involvement*        *Means of diagnosis*   *Treatment*     *Evaluation*
  -------------------- -------------------- ---------------- --------------- ---------- ----------------------------------- ----------------------------------------------------------------------------------- -------------------------------- -------------------------------------- ------------------------ -------------------------------- ---------------------- --------------- --------------
  Koskoff *et al.*     1953                 United States    44                  M      12                                  Bilateral legs paralysis; back aching pain; bilateral lower extremities weakness    Severe, polyarticular, tophi     625                                             T9-T11          Extradural space                 Operation              Decompression   Improved
  Levin *et al.*       1956                 United States    56                  M      35                                  Normal                                                                              Severe, polyarticular, tophi     774                                             T12-L1          Disc; vertebral bodies           Autopsy                ND              NA
  Leaney *et al.*      1983                 Australia        33                  M      5                                   Midthoracic pain; bilateral lower limbs paralysis and weakness; urinary retention   Severe, polyarticular, tophi     560                                             T7-T11          Extradural space; pedicles       Operation              Laminectomy     Improved
  Downey *et al.*      1987                 United Kingdom   73                  M      NR                                  Bilateral legs paralysis; gait disturbance                                          NR                               NR                                                T1            Extradural space                 Operation              NR              NR
  Yasuhara *et al.*    1994                 Japan            60                  M      5                                   Back pain; hypesthesia; bilateral lower extremites weakness                         Mild, Polyarticular tophi        619                                             T6-T7           Extradural space                 Operation              Laminectomy     Improved
  Dhote *et al.*       1997                 France           56                  M      2                                   Bilateral lower extremites paralysis and weakness                                   Severe, polyarticular, tophi     929                                             T4-T9           Extradural space                 Operation              Laminectomy     Improved
  Pfister *et al.*     1998                 United State     53                  F      25                                  Back pain;urinary retention; unilaterial right leg weakness                         Severe, polyarticular, tophi     NR                                              T8-T9           Vertebral bodies                 Needle biopsy          Laminectomy     Improved
  Bret *et al.*        1999                 France           59                  F      16                                  Bilateral lower extremities paralysis and weakness                                  Severe, polyarticular, tophi     340                                             T2-T9           Extradural space                 Operation              Laminectomy     Improved
  Hausch *et al.*      1999                 United State     59                  M      3                                   Back pain;                                                                          Polyarticular, tophi             726                                             T4;T7           Vertebral bodies                 Needle biopsy          Conservative    Improved
  Kaye *et al.*        1999                 South Africa     59                  F      4                                   Bowel and bladder dysfunction; bilateral lower extremites weakness; back pain       Polyarticular, no tophi          NA                                                T8            Vertebral bodies                 Operation              Laminectomy     NR
  Kao *et al.*         2000                 Taiwan           82                  M      5                                   Bilateral lower extremites weakness; urinary retention                              Polyarticular, no tophi          506                                            T10-T11          Extradural space                 Operation              Laminectomy     Improved
  St George *et al.*   2001                 United Kingdom   60                  M      10                                  Unilateral left leg weakness                                                        No tophi                         NR                                              T1-T2           Extradural space                 Operation              Laminectomy     Improved
  Wang *et al.*        2001                 Taiwan           28                  M      5                                   Back pain; bilateral lower extremities paralysis; urinary retention                 Polyarticular, no tophi          601                                             T9-T10          Facet joint; ligamentum flavum   Operation              Laminectomy     Resovled
  Hsu *et al.*         2002                 Taiwan           83                  M      2                                   Bilateral lower extremites weakness and numbness                                    No tophi                         375                                             T9-T11          Ligamentum flavum                Operation              Laminectomy     NR
  Souza *et al.*       2002                 Brazil           49                  M      5                                   Back pain; unilateral right leg weakness; sensory impairment                        Severe, polyarticular, tophi     NR                                              T9-T10          Extradural space                 Operation              Laminectomy     Resovled
  EI Sandid *et al.*   2004                 United States    32                  M      NA                                  Back pain                                                                           No tophi                         620                                             T7-T9           Extradural space                 Operation              Laminectomy     Improved
  Popovich *et al.*    2006                 United States    36                  F      NA                                  Bilateral lower extremites weakness; sensory impaired                               No tophi                         571                                             T4-T7           Pedicles                         Operation              Laminectomy     Resovled
  Chan *et al.*        2009                 Hong Kong        76                  M      NA                                  Bilateral lower extremites weakness                                                 Severe, polyarticular, tophi     NR                                              T8;T10          Pedicles; vertebral bodies       Needle biopsy          Conservative    Improved
  Kwan *et al.*        2013                 Canada           25                  M      NR                                  Back pain                                                                           No tophi                         462                                           T9;T10;T12        Costovertebral joint             Needle biopsy          Conservative    Decreased
  Nasseri *et al.*     2013                 United States    30                  M      NR                                  Back pain; bilateral lower extremities weakness                                     NR                               NR                                             T10-T11          Facet joint                      NR                     NR              NR
  Yoon *et al.*        2013                 Korea            64                  M      8                                   Back pain; bilateral lower extremities weakness                                     NR                               726                                             T6-T7           Facet joint; pedicles            Operation              Laminectomy     Improved

Abbreviations: F, female; M, male; NR, not report; ND, not done; NA, not applicable.
